M. Stoecher

MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.

R. Greil, I. Tinhofer, M. Steurer, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

SNP309 as predictor for sensitivity of CLL cells to the MDM2 inhibitor nutlin-3a.

R. Greil, I. Tinhofer, S. Hofbauer, 2008, Blood.

Inhibition of GLI, but not Smoothened, induces apoptosis in chronic lymphocytic leukemia cells

R. Greil, I. Tinhofer, B. Alinger, 2010, Oncogene.

Expression levels of CD38 in T cells predict course of disease in male patients with B-chronic lymphocytic leukemia.

R. Greil, I. Tinhofer, M. Steurer, 2006, Blood.